| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.07 | 0.03 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.05 |